We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Creating a Clinical Diagnostic Test from Discovery Through Launch with Mass Spectrometry

Video   Apr 14, 2015

 

Recently, we evaluated the performance of 190 candidate protein biomarkers to discriminate between patients with benign or malignant lung nodules.  The candidate markers came from the substantial literature on cancer-associated proteins as well as from mass spectrometry studies, conducted in-house to identify proteins up-regulated either on the surface of tumors or in the secretome of tumors, as compared to adjacent normal lung tissue. Plasma samples were obtained retrospectively for analysis from those with either benign or malignant nodules.  A 13 protein panel was identified with a high negative predictive value, able to remove approximately half of those with benign nodules from further consideration.  The test has been commercialized, using MRM mass spectrometry, by Integrated Diagnostics.

 
 
 
Advertisement
 

Recommended Videos

Aerobic Microbial Life Persists in Oxic Marine Sediments as Old as 101.5 Million Years - Interviews

Video

Scientists incubated ancient sediment samples to coax their microbes to grow. The results demonstrated that rather than being fossilized remains of life, the microbes in the sediment had survived, and were capable of growing and dividing.

WATCH NOW

Teach Me in 10 – Visualizing Biological Processes With Elizabeth Neumann

Video

In this installment of Teach Me in 10, we are delighted to welcome Elizabeth K. Neumann from Vanderbilt University’s Mass Spectrometry Research Center. How can imaging mass spectrometry be used to study biological processes within the body? Watch this Teach Me in 10 to find out!

WATCH NOW

Teach Me in 10 – Understanding COVID-19 Through "Omics" With Dr Clare Paterson

Video

In a COVID-19 special of Teach Me in 10, we're joined by Dr Clare Paterson, senior clinical R&D scientist at SomaLogic, who is currently working on using "omics" approaches to understand the biology of SARS-CoV-2.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Analysis & Separations Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE